Status:
COMPLETED
Responses to Regulated E-Cigarette Advertisements
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use
Eligibility:
All Genders
18-26 years
Phase:
NA
Brief Summary
While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. Specifically, the investigators will conduct a randomized control trial (RCT) w...
Detailed Description
While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. The use of ECs during young adulthood, particularly 18 years of age, is especia...
Eligibility Criteria
Inclusion
- 18 to 26 years old,
- fluent in English (earn a score of at least 4 on the Rapid Estimate of Adult Literacy in Medicine)
- biochemically confirmed abstinence of alcohol (BrAC=.00) and combusted tobacco or marijuana exhaled carbon monoxide (eCO\<6 parts per million) at time of visit,
- reporting never trying an e-cigarette, not even a puff OR reporting tried and e-cigarette in the past but not in the past 30 days. Susceptibility to EC use, will be determined using the Susceptibility to Use Tobacco Products questionnaire, with only those identifying anything besides "no curiosity/interest" to all three susceptibility questions as susceptible users.
Exclusion
- Out of age range 18-26 years
- Use of an e-cigarette in past 30 days
- Pregnant women
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT05207033
Start Date
April 1 2022
End Date
July 1 2024
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMass Chan Medical School Stevens Lab
Worcester, Massachusetts, United States, 01605